XML 62 R48.htm IDEA: XBRL DOCUMENT v3.19.2
Long-Term Investments (Details)
3 Months Ended 12 Months Ended
Mar. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Aug. 31, 2017
Ownership percentage       73.00%
Rgene Corporation [Member]        
Ownership percentage   23.90%  
Accounting treatment   Equity Method    
Braingenesis Biotechnology Co., Ltd. [Member]        
Ownership percentage 0.17% 0.17%    
Accounting treatment Cost Method      
Genepharm Biotech Corporation [Member]        
Ownership percentage 0.72% 0.72%    
Accounting treatment Cost Method      
BioHopeKing Corporation [Member]        
Ownership percentage 7.13% 7.13%    
Accounting treatment Cost Method      
BioFirst Corporation [Member]        
Ownership percentage 16.14% 15.84%    
Accounting treatment Equity Method      
Rgene [Member]        
Ownership percentage 31.63% 31.63%    
Accounting treatment Equity Method